Dopamine synthesis by non-dopaminergic neurons expressing individual complementary enzymes of the dopamine synthetic pathway in the arcuate nucleus of fetal …
MV Ugrumov, VI Melnikova, AV Lavrentyeva, VS Kudrin… - Neuroscience, 2004 - Elsevier
This study was aimed to test our hypothesis about dopamine (DA) synthesis by non-DAergic
neurons expressing individual complementary enzymes of the DA synthetic pathway in …
neurons expressing individual complementary enzymes of the DA synthetic pathway in …
Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons
K Sawamoto, N Nakao, K Kobayashi… - Proceedings of the …, 2001 - National Acad Sciences
To visualize and isolate live dopamine (DA)-producing neurons in the embryonic ventral
mesencephalon, we generated transgenic mice expressing green fluorescent protein (GFP) …
mesencephalon, we generated transgenic mice expressing green fluorescent protein (GFP) …
The degeneration of dopamine neurons in Parkinson's disease: insights from embryology and evolution of the mesostriatocortical system
P Vernier, F Moret, S Callier, M Snapyan… - Annals of the New …, 2004 - Wiley Online Library
Parkinson's disease (PD) is, to a large extent, specific to the human species. Most symptoms
are the consequence of the preferential degeneration of the dopamine‐synthesizing cells of …
are the consequence of the preferential degeneration of the dopamine‐synthesizing cells of …
Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism
Since the late 80s it has been repeatedly shown that besides dopaminergic neurons, the
brain contains so-called monoenzymatic neurons possessing one of the enzymes of …
brain contains so-called monoenzymatic neurons possessing one of the enzymes of …
Synaptic and cellular plasticity in Parkinson's disease
HY Chu - Acta Pharmacologica Sinica, 2020 - nature.com
Parkinson's disease (PD) is a progressive neurodegenerative disease, which causes a
tremendous socioeconomic burden. PD patients are suffering from debilitating motor and …
tremendous socioeconomic burden. PD patients are suffering from debilitating motor and …
Transcriptional control of midbrain dopaminergic neuron development
SL Ang - 2006 - journals.biologists.com
Although loss of midbrain dopaminergic neurons is associated with one of the most common
human neurological disorders, Parkinson's disease, little is known about the specification of …
human neurological disorders, Parkinson's disease, little is known about the specification of …
Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology
F Simunovic, M Yi, Y Wang, L Macey, LT Brown… - Brain, 2009 - academic.oup.com
Parkinson's disease is caused by a progressive loss of the midbrain dopamine (DA) neurons
in the substantia nigra pars compacta. Although the main cause of Parkinson's disease …
in the substantia nigra pars compacta. Although the main cause of Parkinson's disease …
Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum
M Napolitano, D Centonze, A Calce, B Picconi… - Neurobiology of …, 2002 - Elsevier
The irreversible loss of the dopamine-mediated control of striatal function is considered the
functional substrate of the motor symptoms of Parkinson's disease. This pathological event …
functional substrate of the motor symptoms of Parkinson's disease. This pathological event …
Cellular and molecular aspects of Parkinson treatment: future therapeutic perspectives
Parkinson's disease is a neurodegenerative disorder accompanied by depletion of
dopamine and loss of dopaminergic neurons in the brain that is believed to be responsible …
dopamine and loss of dopaminergic neurons in the brain that is believed to be responsible …
Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism
Nigrostriatal dopamine depletion disrupts striatal medium spiny neuron morphology in
Parkinson's disease and modulates striatal synaptic plasticity in animal models of …
Parkinson's disease and modulates striatal synaptic plasticity in animal models of …